A novel approach to the immediate effects of electroacupuncture on dry eye: A case series.

Dry eye disease is a common inflammatory condition that causes uncomfortable symptoms like eye fatigue and dryness. Many patients rely on artificial tears or anti-inflammatory medications for relief, but these treatments often provide limited results and may cause side effects with long-term use. Researchers explored whether electroacupuncture—a technique that combines traditional acupuncture with mild electrical stimulation—could offer a faster, more effective alternative for dry eye sufferers.

This case series followed three patients with dry eye disease who had been experiencing poor results from conventional treatments. Each patient received electroacupuncture therapy targeting specific points near the lacrimal glands (tear-producing glands). The treatment protocol was notably brief, with patients receiving only 3-4 days of treatment.

The results were encouraging. All three patients experienced significant improvements in eye fatigue and dryness after just a few days of treatment. When researchers checked back with patients four weeks later, the improvements had lasted without any signs of symptoms returning. None of the patients experienced adverse reactions or side effects during treatment.

The researchers believe that placing acupuncture needles on both sides of the lacrimal glands and applying continuous electrical stimulation creates an electric field that may enhance the body's natural mechanisms for tear production and eye surface health. This innovative approach offers hope for dry eye patients seeking alternatives to conventional treatments, with the potential for faster relief using fewer treatment sessions.

If you're considering electroacupuncture for dry eye disease, consult with a licensed acupuncturist who has experience treating eye conditions and using electroacupuncture techniques.

This case series examined electroacupuncture (EA) efficacy for dry eye disease (DED) in three patients with poor response to conventional therapies including artificial tears and anti-inflammatory drugs. The novel protocol utilized anatomically positioned needles bilaterally adjacent to the lacrimal glands with continuous electrical stimulation, creating an electric field intended to modulate endogenous tear production mechanisms. Treatment duration was notably brief at 3-4 days per patient. All three patients demonstrated significant improvements in ocular surface fatigue and dryness following treatment, with sustained results at 4-week follow-up and no recurrence tendency. No adverse events were reported. Clinical takeaway: This targeted EA approach using fewer points and shorter treatment duration shows promise for rapid DED symptom relief, though larger controlled trials are needed to validate these preliminary findings. The proposed mechanism involves electrical field modulation of lacrimal gland function through strategically positioned needles.